BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36723927)

  • 1. Myo/Nog Cells Give Rise to Myofibroblasts During Epiretinal Membrane Formation in a Mouse Model of Proliferative Vitreoretinopathy.
    Crispin M; Gerhart J; Heffer A; Martin M; Abdalla F; Bravo-Nuevo A; Philp NJ; Kuriyan AE; George-Weinstein M
    Invest Ophthalmol Vis Sci; 2023 Feb; 64(2):1. PubMed ID: 36723927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myo/Nog cells expressing muscle proteins are present in preretinal membranes from patients with proliferative vitreoretinopathy.
    Gerhart J; Morrison N; Gugerty L; Telander D; Bravo-Nuevo A; George-Weinstein M
    Exp Eye Res; 2020 Aug; 197():108080. PubMed ID: 32474138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myo/Nog cells: targets for preventing the accumulation of skeletal muscle-like cells in the human lens.
    Gerhart J; Greenbaum M; Scheinfeld V; Fitzgerald P; Crawford M; Bravo-Nuevo A; Pitts M; George-Weinstein M
    PLoS One; 2014; 9(4):e95262. PubMed ID: 24736495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-specific angiogenesis inhibitor 1 is expressed in the Myo/Nog cell lineage.
    Gerhart J; Bowers J; Gugerty L; Gerhart C; Martin M; Abdalla F; Bravo-Nuevo A; Sullivan JT; Rimkunas R; Albertus A; Casta L; Getts L; Getts R; George-Weinstein M
    PLoS One; 2020; 15(7):e0234792. PubMed ID: 32614850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of gene expression profile of epiretinal membranes obtained from eyes with proliferative vitreoretinopathy to that of secondary epiretinal membranes.
    Asato R; Yoshida S; Ogura A; Nakama T; Ishikawa K; Nakao S; Sassa Y; Enaida H; Oshima Y; Ikeo K; Gojobori T; Kono T; Ishibashi T
    PLoS One; 2013; 8(1):e54191. PubMed ID: 23372684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Cell Protein and Transcriptional Characterization of Epiretinal Membranes From Patients With Proliferative Vitreoretinopathy.
    Laich Y; Wolf J; Hajdu RI; Schlecht A; Bucher F; Pauleikhoff L; Busch M; Martin G; Faatz H; Killmer S; Bengsch B; Stahl A; Lommatzsch A; Schlunck G; Agostini H; Boneva S; Lange C
    Invest Ophthalmol Vis Sci; 2022 May; 63(5):17. PubMed ID: 35579905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myo/Nog Cells: The Jekylls and Hydes of the Lens.
    Gerhart J; George-Weinstein M
    Cells; 2023 Jun; 12(13):. PubMed ID: 37443759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration.
    Oberstein SY; Byun J; Herrera D; Chapin EA; Fisher SK; Lewis GP
    Mol Vis; 2011; 17():1794-805. PubMed ID: 21750605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells.
    Wong CA; Potter MJ; Cui JZ; Chang TS; Ma P; Maberley AL; Ross WH; White VA; Samad A; Jia W; Hornan D; Matsubara JA
    Can J Ophthalmol; 2002 Jun; 37(4):211-20. PubMed ID: 12095094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
    Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
    Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of Myo/Nog Cells in the Lens Mitigates Posterior Capsule Opacification in Rabbits.
    Gerhart J; Werner L; Mamalis N; Infanti J; Withers C; Abdalla F; Gerhart C; Bravo-Nuevo A; Gerhart O; Getts L; Rhodes K; Bowers J; Getts R; George-Weinstein M
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):1813-1823. PubMed ID: 31042787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy.
    Bochaton-Piallat ML; Kapetanios AD; Donati G; Redard M; Gabbiani G; Pournaras CJ
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2336-42. PubMed ID: 10892881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aquaporin-1 expression in proliferative vitreoretinopathy and in epiretinal membranes.
    Motulsky E; Salik D; Janssens X; Pion B; Dufrane R; Chaput F; Bolaky N; Gregoire F; Caspers L; Perret J; Willermain F; Delporte C
    ScientificWorldJournal; 2014; 2014():876208. PubMed ID: 24688444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of myofibroblast activation molecules in proliferative vitreoretinopathy epiretinal membranes.
    Abu El-Asrar AM; Missotten L; Geboes K
    Acta Ophthalmol; 2011 Mar; 89(2):e115-21. PubMed ID: 20528783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myo/Nog cells are present in the ciliary processes, on the zonule of Zinn and posterior capsule of the lens following cataract surgery.
    Gerhart J; Withers C; Gerhart C; Werner L; Mamalis N; Bravo-Nuevo A; Scheinfeld V; FitzGerald P; Getts R; George-Weinstein M
    Exp Eye Res; 2018 Jun; 171():101-105. PubMed ID: 29559302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive circular RNA profiling of proliferative vitreoretinopathy and its clinical significance.
    Yao J; Hu LL; Li XM; Shan K; Zhou RM; Ge HM; Yao MD; Jiang Q; Zhao C; Yan B
    Biomed Pharmacother; 2019 Mar; 111():548-554. PubMed ID: 30597308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyosarcoma and Wilms tumors contain a subpopulation of noggin producing, myogenic cells immunoreactive for lens beaded filament proteins.
    Gerhart J; Behling K; Paessler M; Milton L; Bramblett G; Garcia D; Pitts M; Hurtt R; Crawford M; Lackman R; Nguyen D; Infanti J; FitzGerald P; George-Weinstein M
    PLoS One; 2019; 14(4):e0214758. PubMed ID: 30973903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes.
    Telander DG; Yu AK; Forward KI; Morales SA; Morse LS; Park SS; Gordon LK
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3112-7. PubMed ID: 27294805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Mouse Model of Proliferative Vitreoretinopathy Induced by Intravitreal Injection of Gas and RPE Cells.
    Heffer A; Wang V; Sridhar J; Feldon SE; Libby RT; Woeller CF; Kuriyan AE
    Transl Vis Sci Technol; 2020 Jun; 9(7):9. PubMed ID: 32832216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.